ClinicalTrials.Veeva

Menu

Functional Assessment of Patients With Acute Bipolar Depression After 8 Months of Follow-up

AstraZeneca logo

AstraZeneca

Status

Completed

Conditions

Bipolar Disorder
Bipolar Depression

Study type

Observational

Funder types

Industry

Identifiers

NCT01255982
NIS-NES-DUM-2010/1

Details and patient eligibility

About

This study aims to study prospectively for 8 months a sample of bipolar patients with acute depressive episode in order to identify that factors associated with functional impairment, with especial attention to the presence of subsyndromal symptoms beyond the acute phase.

Enrollment

249 patients

Sex

All

Ages

18 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of Bipolar Disorder I or II (DSM-IV-TR)
  • Acute depressive episode at inclusion

Exclusion criteria

  • Inability (in investigator´s opinion) to carry out the follow-up plan
  • Patients participating or having participated within previous 6 months, in clinical trials
  • Mental retardation or any other medical condition affecting cognitive performance

Trial design

249 participants in 1 patient group

1
Description:
Diagnosed with bipolar I or II disorder, and with an acute episode of bipolar depression at inclusion

Trial contacts and locations

24

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems